WRBY

Warby Parker Inc.
NYSEUSDEQUITY Healthcare DELAYED
Last price
26.23
▼ 0.42 (1.58%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
26.65
Prev close
26.65
Day high
26.88
Day low
25.90
Volume
3.26M
Market cap
$3.24B
P/E (TTM)
437.17
52W range
14.96 – 31.00

Day trading desk

Current session · delayed
Gap from prior close
+0.00%
Prior close 26.65
VWAP
26.25
-0.07% from price
Relative volume
2.51×
Unusually busy
Session range
3.86%
25.90 – 26.90
Position in range
33%
Mid range
ATR (14D)
1.72
6.55% of price
Prior day high
27.02
PDH
Prior day low
25.58
PDL
Bid / ask spread
—
Quote not published
Session volume
7.14M
Avg 2.84M

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.51% -6.5%
1M
+7.72% +6.6%
3M
-5.20% -9.7%
6M
+23.78% +5.6%
YTD
+20.38% +6.1%
1Y
+0.04% -16.4%
3Y
+99.32% +17.1%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on WRBY open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
+424.90K
Net buying
Buy transactions
19
1.21M shares
Sell transactions
11
785.27K shares
Net transactions
+30
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
6.94M
Total on file
Bought 1.21MSold 785.27K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Sep 2, 26
GILBOA DAVID ABRAHAM
Chief Executive Officer
— 20.80K — Direct
Sep 2, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
— 20.80K — Direct
Aug 12, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
CONVERSION 200.00K $5.06M Direct
Jul 6, 26
GILBOA DAVID ABRAHAM
Chief Executive Officer
— 54.35K — Direct
Jul 6, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
— 9.20K — Direct
Jul 6, 26
GILBOA DAVID ABRAHAM
Chief Executive Officer
SELL 54.35K $1.62M Direct
Jul 6, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
SELL 9.20K $275.91K Direct
Jul 1, 26
GILBOA DAVID ABRAHAM
Chief Executive Officer
— 213.75K — Direct
Jul 1, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
— 189.32K — Direct
Jul 1, 26
GILBOA DAVID ABRAHAM
Chief Executive Officer
SELL 242.22K $7.19M Direct
Jul 1, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
SELL 217.67K $6.45M Direct
Jul 1, 26
RAIDER JEFFREY JACOB
Director
SELL 22.50K $668.70K Direct
Jun 29, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
— 36.30K — Direct
Jun 29, 26
BLUMENTHAL NEIL HARRIS
Chief Executive Officer
SELL 36.30K $1.09M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BLUMENTHAL NEIL HARRIS
Chief Executive Officer 440.41K Conversion of Exercise of derivative security
BRIGGS TERESA
Director 64.85K Sale
CUTLER JOEL E
Director — Stock Gift
GILBOA DAVID ABRAHAM
Chief Executive Officer 40.41K Conversion of Exercise of derivative security
HUNT ANDREW
Director 1.94M Stock Award(Grant)
MILLER STEVEN CLIVE
Chief Financial Officer 233.12K Conversion of Exercise of derivative security
MOON YOUNGME E
Director 26.06K Sale
RAIDER JEFFREY JACOB
Director 2.61M Sale
SINGER BRADLEY E
Director 125.03K Stock Award(Grant)
WILLIAMS RONALD A
Director 122.80K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap$3.24B
Enterprise value$3.20B
Revenue (TTM)$911.61M
Gross profit$484.23M
EBITDA$41.47M
Net income$7.74M
EPS (TTM)$0.06
Free cash flow$9.53M
Total cash$292.67M
Total debt$250.98M
Book value / share$3.18
Shares outstanding108.24M
Float96.79M
Short % of float20.27%
Dividend yield0.00%
Beta (5Y)1.90

Valuation & profitability ratios

Account required
Trailing P/E437.17
Forward P/E42.67
PEG ratio—
Price / sales—
Price / book8.26
EV / revenue3.51
EV / EBITDA77.18
Gross margin53.12%
Operating margin-3.60%
Profit margin0.85%
Return on equity2.06%
Return on assets-1.02%
Debt / equity64.03
Current ratio2.27
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 5 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $871.90M$771.32M$669.76M$598.11M +13.0%
Operating revenue $871.90M$771.32M$669.76M$598.11M +13.0%
Cost of revenue $401.33M$344.48M$304.54M$257.05M +16.5%
Gross profit $470.58M$426.83M$365.22M$341.06M +10.2%
Selling, general & admin $475.92M$456.95M$437.22M$452.26M +4.2%
Total operating expense $475.92M$456.95M$437.22M$452.26M +4.2%
Operating income -$5.34M-$30.11M-$72.00M-$111.20M +82.3%
Net interest income $8.38M$10.60M$9.23M$1.31M -20.9%
Pre-tax income $3.04M-$19.52M-$62.76M-$109.90M +115.6%
Tax provision $1.40M$875.00K$433.00K$497.00K +60.2%
Net income $1.64M-$20.39M-$63.20M-$110.39M +108.0%
Net income to common $1.64M-$20.39M-$63.20M-$110.39M +108.0%
Basic EPS 0.01-0.17-0.54-0.96 +105.9%
Diluted EPS 0.01-0.17-0.54-0.96 +105.9%
EBIT -$5.34M-$30.11M-$72.00M-$111.20M +82.3%
EBITDA $44.94M$15.75M-$33.44M-$79.34M +185.3%
Basic shares 122.67M120.39M117.39M114.94M +1.9%
Diluted shares 122.67M120.39M117.39M114.94M +1.9%

Options analytics

Account required
Put / call volume
4.08
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
14.00
-46.6% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
88
Contracts, this expiry
Put volume
359
Contracts, this expiry
Heaviest call OI
22.00
0 contracts
Heaviest put OI
14.00
0 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 0.110.15 +30.0%
Mar 2026 0.110.11 +3.8%
Dec 2025 0.050.02 -58.3%
Sep 2025 0.090.12 +38.1%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter 0.09 9 $245.04M +10.5%
Next quarter 0.10 10 $248.16M +17.1%
Current year 0.42 9 $971.14M +11.4%
Next year 0.61 9 $1.14B +17.1%

Analyst targets & ownership

Account required
Mean target$30.46
High target$35.00
Low target$24.00
Implied upside16.13%
Analyst count13
ConsensusBUY
Strong buy / Buy2 / 8
Hold4
Sell / Strong sell0 / 0
Held by insiders5.61%
Held by institutions116.65%
Institutions holding409
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
26.36
-0.51% from price
SMA 20
25.18
+4.15% from price
SMA 50
25.71
+2.02% from price
SMA 100
26.04
+0.74% from price
SMA 200
25.21
+4.04% from price
EMA 12
26.10
+0.52% from price
EMA 26
25.63
+2.34% from price
EMA 50
25.62
+2.37% from price
RSI (14)
52.8
Neutral
MACD (12,26,9)
0.46
Hist 0.29
ATR (14)
1.72
6.55% of price
Realised vol 30D
65.5%
Annualised
Bollinger upper
28.44
20, 2σ
Bollinger lower
21.93
20, 2σ
50 / 200 cross
Golden
25.71 vs 25.21
Trend bias
Above 200
+4.04%

Options chain

Account required
Expiry
Spot 26.23
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
2.06
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
65.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-35.0%
Peak to trough
Max drawdown 5Y
-83.7%
Peak to trough
ATR 14
1.72
6.55% of price
Beta (reported)
1.90
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
17.62M
Prior 18.12M
Change vs prior
-2.7%
Shorts covering
% of float
20.27%
Heavily shorted
% of shares out
14.26%
Against total outstanding
Days to cover
7.7
Crowded exit
Float
96.79M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

118 on file
DateFirm ActionFromTo
Aug 7, 26 UBS MAINTAINED Neutral Neutral
Aug 7, 26 Citizens MAINTAINED Market Outperform Market Outperform
Jun 29, 26 B of A Securities INITIATED — Buy
May 8, 26 UBS MAINTAINED Neutral Neutral
May 7, 26 BTIG MAINTAINED Buy Buy
Mar 17, 26 Citigroup MAINTAINED Neutral Neutral
Feb 20, 26 Telsey Advisory Group MAINTAINED Outperform Outperform
Feb 10, 26 Telsey Advisory Group MAINTAINED Outperform Outperform
Dec 16, 25 Piper Sandler MAINTAINED Overweight Overweight
Dec 12, 25 Stifel MAINTAINED Hold Hold
Dec 11, 25 BTIG MAINTAINED Buy Buy
Nov 18, 25 Telsey Advisory Group MAINTAINED Outperform Outperform

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.